Photo Source: Vishnevsky National Research Medical Center of Surgery
A proposed procedure for including technologies in this registry has also been developed. Among the main selection criteria, the technique must not have been previously utilized in Russia.
The registry will be available for review by the medical community. For each novel treatment and diagnostic modality, scientific justification of the technology's novelty and effectiveness, composition and cost of medical procedures will be specified.
Technologies are evaluated in federal clinics of the Ministry of Health and other agencies, National Medical Research Centers (NMRC). Following trials, technology application results are analyzed, then it enters clinical practice guidelines, meaning it becomes officially permitted for use and reimbursement in clinics throughout the country.
According to the ministry, in 2021-2023, federal clinics studied 1,268 new types of medical care; as of 2024, 169 of them were incorporated into clinical practice guidelines. According to the initiative's authors, creating the registry will increase the number of techniques launched into practice.
Russia previously identified priorities in developing promising medical technologies at the state level. The list includes personalized and cellular products (including CAR-T therapy), bioprinting and tissue engineering, radiopharmaceuticals for nuclear medicine, genetic technologies, neuroprosthetics, and artificial intelligence-based systems. More details about them in the Marus Media overview.
Source: Kommersant. Health+
All information on this website is provided for informational purposes only and does not constitute medical advice. All medical procedures require prior consultation with a licensed physician. Treatment outcomes may vary depending on individual characteristics. We do not guarantee any specific results. Always consult a medical professional before making any healthcare decisions.
